Growth Metrics

Armata Pharmaceuticals (ARMP) Payables (2016 - 2026)

Quarterly results put Payables at $1.4 million for Q1 2026, up 128.75% from a year ago — trailing twelve months through Mar 2026 was $1.4 million (up 128.75% YoY), and the annual figure for FY2025 was $1.7 million, down 17.03%.

Armata Pharmaceuticals has reported Payables over the past 14 years, most recently at $1.4 million for Q1 2026.

  • Payables reached $1.4 million in Q1 2026 per ARMP's latest filing, down from $1.7 million in the prior quarter.
  • Across five years, Payables topped out at $37.4 million in Q1 2023 and bottomed at $633000.0 in Q1 2025.
  • Median Payables over the past 5 years was $2.1 million (2024), compared with a mean of $6.6 million.
  • The largest annual shift saw Payables skyrocketed 987.81% in 2023 before it plummeted 98.03% in 2024.
  • Over 5 years, Payables stood at $6.0 million in 2022, then tumbled by 82.05% to $1.1 million in 2023, then skyrocketed by 89.75% to $2.1 million in 2024, then dropped by 17.03% to $1.7 million in 2025, then decreased by 15.07% to $1.4 million in 2026.
  • Business Quant data shows Payables for ARMP at $1.4 million in Q1 2026, $1.7 million in Q4 2025, and $1.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 300,549.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 1.05 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 83.00 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 10.62 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 8.69 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 489.30 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 1.03 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 126.63 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - 1.45 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.45 Mn
Dec 31, 2025 1.71 Mn
Sep 30, 2025 1.28 Mn
Jun 30, 2025 965,000.00
Mar 31, 2025 633,000.00
Dec 31, 2024 2.06 Mn
Sep 30, 2024 1.82 Mn
Jun 30, 2024 3.85 Mn
Mar 31, 2024 736,000.00
Dec 31, 2023 1.08 Mn
Sep 30, 2023 6.70 Mn
Jun 30, 2023 35.94 Mn
Mar 31, 2023 37.39 Mn
Dec 31, 2022 6.03 Mn
Sep 30, 2022 2.98 Mn
Jun 30, 2022 4.02 Mn
Mar 31, 2022 3.44 Mn
Dec 31, 2021 1.14 Mn
Sep 30, 2021 1.81 Mn
Jun 30, 2021 2.30 Mn
Mar 31, 2021 1.76 Mn
Dec 31, 2020 1.93 Mn
Sep 30, 2020 1.87 Mn
Jun 30, 2020 1.50 Mn
Mar 31, 2020 1.45 Mn
Dec 31, 2019 731,000.00
Sep 30, 2019 1.26 Mn
Jun 30, 2019 1.77 Mn
Mar 31, 2019 1.76 Mn
Dec 31, 2018 574,000.00
Sep 30, 2018 714,000.00
Jun 30, 2018 682,000.00
Mar 31, 2018 810,000.00
Dec 31, 2017 340,000.00
Sep 30, 2017 1.29 Mn
Jun 30, 2017 2.50 Mn
Mar 31, 2017 1.75 Mn
Dec 31, 2016 1.59 Mn
Sep 30, 2016 3.13 Mn
Jun 30, 2016 3.21 Mn